SAN DIEGO, Sept. 19, 2011 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced that Stephen J. Farr, Ph.D., President and Chief Operating Officer, and Ann Rhoads, Executive Vice President and Chief Financial Officer, will be presenting at the UBS 2011 Global Life Sciences Conference on September 21, 2011 at the Grand Hyatt hotel in New York, NY.
